The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice
Abstract
B cells can serve dual roles in modulating T cell immunity through their potent capacity to present Ag and induce regulatory tolerance. Although B cells are necessary components for the initiation of spontaneous T cell autoimmunity to β cell Ags in nonobese diabetic (NOD) mice, the role of activated B cells in the autoimmune process is poorly understood. In this study, we show that LPS-activated B cells, but not control B cells, express Fas ligand and secrete TGF-β. Coincubation of diabetogenic T cells with activated B cells in vitro leads to the apoptosis of both T and B lymphocytes. Transfusion of activated B cells, but not control B cells, into prediabetic NOD mice inhibited spontaneous Th1 autoimmunity, but did not promote Th2 responses to β cell autoantigens. Furthermore, this treatment induced mononuclear cell apoptosis predominantly in the spleen and temporarily impaired the activity of APCs. Cotransfer of activated B cells with diabetogenic splenic T cells prevented the adoptive transfer of type I diabetes mellitus (T1DM) to NOD/scid mice. Importantly, whereas 90% of NOD mice treated with control B cells developed T1DM within 27 wk, <20% of the NOD mice treated with activated B cells became hyperglycemic up to 1 year of age. Our data suggest that activated B cells can down-regulate pathogenic Th1 immunity through triggering the apoptosis of Th1 cells and/or inhibition of APC activity by the secretion of TGF-β. These findings provide new insights into T-B cell interactions and may aid in the design of new therapies for human T1DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., & Weiner, H. L. (1994) · Science · doi:10.1126/science.7520605 · Cited by 1,973
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., & Lehmann, P. V. (1993) · Nature · doi:10.1038/366069a0 · Cited by 1,070
Self-citationPowrie, F., Carlino, J., Leach, M. W., Mauze, S., & Coffman, R. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2669 · Cited by 894
Signals and signs for lymphocyte responses
Janeway, C. A., & Bottomly, K. (1994) · Cell · doi:10.1016/0092-8674(94)90335-2 · Cited by 848
Peripheral deletion of antigen-reactive T cells in oral tolerance
Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V. K., & Weiner, H. L. (1995) · Nature · doi:10.1038/376177a0 · Cited by 783
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat
Castano, L., & Eisenbarth, G. S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003243 · Cited by 644
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
Süss, G., & Shortman, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1789 · Cited by 631
Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H., & Shultz, L. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.2049 · Cited by 583
Remick, D. G., Newcomb, D. E., Bolgos, G. L., & Call, D. R. (2000) · Shock · doi:10.1097/00024382-200013020-00004 · Cited by 534
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Lafaille, J. J., Keere, F. V. D., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Daniel, D., & Wegmann, D. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.956 · Cited by 406
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
Finkelman, F. D., Lees, A., Birnbaum, R., Gause, W. C., & Morris, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1406 · Cited by 319
Constant, S., Schweitzer, N., West, J., Ranney, P., & Bottomly, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3734 · Cited by 302
Tian, J., Clere-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M. A., Mullen, Y., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1348 · Cited by 259
Self-citationFalcone, M., Lee, J., Patstone, G., Yeung, B., & Sarvetnick, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1163 · Cited by 254
Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. W., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., et al. (1999) · PubMed · Cited by 229
Pakala, S. V., Kurrer, M. O., & Katz, J. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.299 · Cited by 217
Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. S., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.743 · Cited by 210
Activated B cells express functional Fas ligand
Hahne, M., Renno, T., Schroeter, M., Irmler, M., French, L., Bornand, T., MacDonald, H. R., & Tschopp, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260332 · Cited by 201
The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice.
Kurt-Jones, E. A., Liano, D., HayGlass, K. A., Benacerraf, B., Sy, M. S., & Abbas, A. K. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.11.3773 · Cited by 192
Do B cells drive the diversification of immune responses?
Mamula, M. J., & Janeway, C. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90274-o · Cited by 185
TGF-β1 Alters APC Preference, Polarizing Islet Antigen Responses toward a Th2 Phenotype
King, C., Davies, J., Mueller, R., Lee, M.-S., Krahl, T., Yeung, B., O'Connor, E., & Sarvetnick, N. (1998) · Immunity · doi:10.1016/s1074-7613(00)80565-8 · Cited by 181
Elias, D., Meilin, A., Ablamunits, V., Birk, O. S., Carmi, P., Könen-Waisman, S., & Cohen, I. R. (1997) · Diabetes · doi:10.2337/diab.46.5.758 · Cited by 177
Deng, H., Apple, R. J., Clare-Salzler, M. J., Trembleau, S., Mathis, D. J., Adorini, L., & Sercarz, E. E. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1675 · Cited by 141
Determinant Spreading of T Helper Cell 2 (Th2) Responses to Pancreatic Islet Autoantigens
Tian, J., Lehmann, P., & Kaufman, D. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2039 · Cited by 134
Self-citationHASKINS, K. M., & Wegmann, D. R. (1996) · Diabetes · doi:10.2337/diab.45.10.1299 · Cited by 128
T cells commit suicide, but B cells are murdered!
Scott, D. W., Grdina, T., & Shi, Y. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2352 · Cited by 83
Elias, D., Meilin, A., Ablamunits, V., Birk, O. S., Carmi, P., Könen‐Waisman, S., & Cohen, I. R. (1997) · Diabetes · doi:10.2337/diabetes.46.5.758 · Cited by 67
Rossi‐Bergmann, B., Müller, I., & Godinho, E. B. (1993) · Infection and Immunity · doi:10.1128/iai.61.5.2266-2269.1993 · Cited by 56
Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
Tisch, R., & McDevitt, H. O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.437 · Cited by 47
Protection of T cells from activation-induced cell death by Fas+ B cells
Wang, J. K., Ju, S., & Marshak‐Rothstein, A. (2000) · European Journal of Immunology · Cited by 13
Cited by
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
Regulatory B Cells: Origin, Phenotype, and Function
Rosser, E. C., & Mauri, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.005 · Cited by 1,455
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
B cell regulation in cancer and anti-tumor immunity
Sarvaria, A., Madrigal, J. A., & Saudemont, A. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.35 · Cited by 630
Metadata
- Authors
- Tian, J., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A., & Kaufman, D. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07
- Volume
- 167
- Issue
- 2
- Pages
- 1081-1089
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1512851684
- Cited by
- 412
- References
- 38
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.